Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Del Ben, Maria ^a   Fabiani, Mario ^a   Loffredo, Lorenzo ^a   Polimeni, Licia ^a   Carnevale, Roberto ^a   Baratta, Francesco ^a   Brunori, Marco ^a   Albanese, Fabiana ^a   Augelletti, Teresa ^a   Violi, Francesco ^a   Angelico, Francesco ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; NITRATE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ADULT; APNEA HYPOPNEA INDEX; ARTERY DISEASE; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SNORING; VASODILATATION;

ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DINOPROST; FEMALE; HUMANS; LINEAR MODELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NADPH OXIDASE; NITRATES; NITRITES; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; VASODILATION;

EID: 84864800165     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-36     Document Type: Article

References (50)

1. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978, 44:931-938.
2. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnoea: implications for cardiac and vascular disease. JAMA 2003, 290:1906-1914. 10.1001/jama.290.14.1906, 14532320.
3. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003, 41:1429-1437. 10.1016/S0735-1097(03)00184-0, 12742277.
4. Angelico F, Del Ben M, Augelletti T, et al. Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting. Eur J Intern Med 2010, 21:191-195. 10.1016/j.ejim.2010.03.006, 20493421.
5. Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006, 40:1683-1692. 10.1016/j.freeradbiomed.2006.01.008, 1995030, 16678006.
6. Lee SD, Ju G, Choi JA, Kim JW, Yoon IY. The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath 2011, 16:511-517.
7. Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000, 16:644-647. 10.1034/j.1399-3003.2000.16d13.x, 11106206.
8. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004, 27:123-128.
9. Katsoulis K, Kontakiotis T, Spanogiannis D. Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease. Sleep Breath 2011, 15:861-866. 10.1007/s11325-010-0456-y, 21267664.
10. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003, 124:1386-1392. 10.1378/chest.124.4.1386, 14555570.
11. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011, 364:656-665. 10.1056/NEJMra0910283, 21323543.
12. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005, 69:221-226. 10.1253/circj.69.221, 15671617.
13. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000, 162:2166-2171.
14. Joannides R, Haefeli WE, Linder L. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-1319. 10.1161/01.CIR.91.5.1314, 7867167.
15. Cooke JP. Flow, NO and atherogenesis. ProcNatlAcadSci U S A 2003, 100:768-770.
16. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265.
17. Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep 2007, 30:997-1001. 1978380, 17702269.
18. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004, 169:354-360.
19. Oflaz H, Cuhadaroglu C, Pamukcu B, et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006, 73:751-756. 10.1159/000094183, 16804287.
20. Chung S, Yoon IY, Lee CH, Kim JW. The association of nocturnal hypoxemia with arterial stiffness and endothelial dysfunction in male patients with obstructive sleep apnea syndrome. Respiration 2010, 79:363-369. 10.1159/000228905, 19602870.
21. Chung S. Endothelial dysfunction and inflammatory reactions of eldery and middle aged men with obstructive sleep apnea syndrome. Sleep Breath 2009, 13:11-17. 10.1007/s11325-008-0210-x, 18777130.
22. Duchna HW, Stoohs R, Guilleminault C, et al. Vascular endothelial dysfunction in patients with mild obstructive sleep apnea syndrome. Wien Med Wochenschr 2006, 156:596-604. 10.1007/s10354-006-0341-2, 17160377.
23. Jurado-Gámez B, Fernandez-Marin MC, Gómez-Chaparro JL, et al. Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J 2011, 37:873-879. 10.1183/09031936.00027910, 20650989.
24. Fleetham J, Ayas N, Bradley D, , et al. CTS Sleep Disordered Breathing Committee Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J 2006, 13:387-392. 2683294, 17036094, CTS Sleep Disordered Breathing Committee.
25. Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 2009, 10:87-94. 10.1016/j.sleep.2007.10.011, 18077211.
26. Büchner NJ, Quack I, Woznowski M, Stähle C, Wenzel U, Rump LC. Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration 2011, 82:409-417. 10.1159/000323266, 21311167.
27. Murri M, Alcázar-Ramírez J, Garrido-Sánchez L, et al. Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients. Transl Res 2009, 3:111-121.
28. Hernandez C, Abreu J, Abreu P, Colino R, Jimenez. Effects of nasal positive airway pressure treatment on oxidative stress in patients with sleep apnea-hypopnea sindrome. Arch Bronconeumol 2006, 42:125-126.
29. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278. 10.1161/CIRCULATIONAHA.107.741512, 2844329, 18413499.
30. Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 2009, 187:17-22. 10.1007/s00408-008-9115-5, 18795367.
31. Bayram NA, Ciftci B, Keles T, et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009, 32:1257-1263. 2753804, 19848355.
32. Ciccone MM, Favale S, Scicchitano P, et al. Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol 2011, 158:383-386.
33. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176:706-712. 10.1164/rccm.200703-500OC, 17556718.
34. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
35. Pignatelli P, Carnevale R, Cangemi R, et al. Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. ArteriosclerThrombVascBiol 2010, 30:360-367.
36. Wang Z, Ciabattoni G, Créminon C, et al. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 1995, 275:94-100.
37. Praticò D. Prostanoid and isoprostanoid pathways in atherogenesis. Atherosclerosis 2008, 201:8-16. 10.1016/j.atherosclerosis.2008.04.037, 18514200.
38. Cave AC, Brewer AC, Narayanapanicker A, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006, 8:691-728. 10.1089/ars.2006.8.691, 16771662.
39. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest 2005, 127:1674-1679. 10.1378/chest.127.5.1674, 15888845.
40. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J RespirCrit Care Med 2002, 165:934-939.
41. Wali SO, Bahammam AS, Massaeli H, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998, 21:290-296.
42. Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005, 26:2435-2439. 10.1093/eurheartj/ehi440, 16105851.
43. Grebe M, Eisele HJ, Weissmann N, et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J RespirCrit Care Med 2006, 173:897-901.
44. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102:2607-2610. 10.1161/01.CIR.102.21.2607, 11085964.
45. Chung S, Yoon IY, Lee CH, Kim JW. The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome. Sleep Breath 2011, 15:71-76. 10.1007/s11325-009-0323-x, 20084550.
46. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J RespirCrit Care Med 2004, 169:348-353.
47. Angelico F, Loffredo L, Pignatelli P, et al. Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome. Intern Emerg Med 2011, 7:219-227.
48. Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021. 10.1161/CIRCULATIONAHA.109.900357, 2864627, 20159829.
49. Zhan G, Serrano F, Fenik P, et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J RespirCrit Care Med 2005, 172:921-929.
50. Dingli K, Coleman EL, Vennelle M, et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. EurRespir J 2003, 21:253-259.